A new deal in HIV prevention: lessons from the global approach

MS Cohen; G Dallabetta; M Laga; KK Holmes

doi:10.7326/0003-4819-120-4-199402150-00014

A new deal in HIV prevention: lessons from the global approach

MS Cohen, G Dallabetta, M Laga, KK Holmes

Sexual Health including HIV

Research output: Contribution to journal › Editorial › peer-review

Abstract

We have now entered the second decade of the human immunodeficiency virus (HIV) pandemic. Medical science has responded to this new disease with remarkable dissection of the HIV virus and equally detailed descriptions of the clinical evolution of opportunistic infections and neoplasms in patients with the acquired immunodeficiency syndrome (AIDS). An entire industry has developed to address and improve strategies for the management of patients with HIV disease. Much of the funding for HIV research in the United States has focused on the development of vaccines [1] and antiviral therapy [2]. In essence, it was (and might still be) …

Original language	English
Journal	Annals of Internal Medicine
Volume	120
Issue number	4
Pages (from-to)	340-341
Number of pages	2
ISSN	0003-4819
DOIs	https://doi.org/10.7326/0003-4819-120-4-199402150-00014
Publication status	Published - 1994

Keywords

B780-tropical-medicine
Viral diseases
HIV
Control
Policy
Sexually transmitted diseases
STD
General practice
USA

Access to Document

10.7326/0003-4819-120-4-199402150-00014

Cite this

@article{0ee8feacbe78437c871319c5863acde0,

title = "A new deal in HIV prevention: lessons from the global approach",

abstract = "We have now entered the second decade of the human immunodeficiency virus (HIV) pandemic. Medical science has responded to this new disease with remarkable dissection of the HIV virus and equally detailed descriptions of the clinical evolution of opportunistic infections and neoplasms in patients with the acquired immunodeficiency syndrome (AIDS). An entire industry has developed to address and improve strategies for the management of patients with HIV disease. Much of the funding for HIV research in the United States has focused on the development of vaccines [1] and antiviral therapy [2]. In essence, it was (and might still be) …",

keywords = "B780-tropical-medicine, Viral diseases, HIV, Control, Policy, Sexually transmitted diseases, STD, General practice, USA",

author = "MS Cohen and G Dallabetta and M Laga and KK Holmes",

note = "FTX: Available in ITM print journal collection. ",

year = "1994",

doi = "10.7326/0003-4819-120-4-199402150-00014",

language = "English",

volume = "120",

pages = "340--341",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "4",

}

TY - JOUR

T1 - A new deal in HIV prevention: lessons from the global approach

AU - Cohen, MS

AU - Dallabetta, G

AU - Laga, M

AU - Holmes, KK

N1 - FTX: Available in ITM print journal collection.

PY - 1994

Y1 - 1994

N2 - We have now entered the second decade of the human immunodeficiency virus (HIV) pandemic. Medical science has responded to this new disease with remarkable dissection of the HIV virus and equally detailed descriptions of the clinical evolution of opportunistic infections and neoplasms in patients with the acquired immunodeficiency syndrome (AIDS). An entire industry has developed to address and improve strategies for the management of patients with HIV disease. Much of the funding for HIV research in the United States has focused on the development of vaccines [1] and antiviral therapy [2]. In essence, it was (and might still be) …

AB - We have now entered the second decade of the human immunodeficiency virus (HIV) pandemic. Medical science has responded to this new disease with remarkable dissection of the HIV virus and equally detailed descriptions of the clinical evolution of opportunistic infections and neoplasms in patients with the acquired immunodeficiency syndrome (AIDS). An entire industry has developed to address and improve strategies for the management of patients with HIV disease. Much of the funding for HIV research in the United States has focused on the development of vaccines [1] and antiviral therapy [2]. In essence, it was (and might still be) …

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - Control

KW - Policy

KW - Sexually transmitted diseases

KW - STD

KW - General practice

KW - USA

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:A1994MW10300014

U2 - 10.7326/0003-4819-120-4-199402150-00014

DO - 10.7326/0003-4819-120-4-199402150-00014

M3 - Editorial

SN - 0003-4819

VL - 120

SP - 340

EP - 341

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 4

ER -

A new deal in HIV prevention: lessons from the global approach

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this